David L. Smith

Associate Director for Research and Senior Fellow

David L Smith is a Professor in the Department of Epidemiology at Johns Hopkins University, the Johns Hopkins Bloomberg School of Public Health, and the Johns Hopkins Malaria Research Institute. He is also a Senior Fellow and Associate Director for Research at the Center for Disease Dynamics, Economics & Policy.  His research deals with the ecology, epidemiology, and economics of infectious diseases, the evolution of resistance to antibiotics and antimalarial drugs, and applied questions about infectious disease dynamics, control and intervention policy. His publications on malaria, flu, cholera, rabies, hospital-acquired infections, agricultural antibiotic use, and MRSA have appeared in top journals Science, Nature, The Lancet, Proceedings of the National Academy of Sciences USA, PLoS Biology, PLoS Medicine.

Smith is a member of the Malaria Atlas Project (MAP), the Malaria Elimination Group (MEG), the Malaria Eradication Research Agenda (MalERA), and The Human Mobility Mapping Project (THUMMP). He consulted with the Zanzibar Minister of Health and the Zanzibar Malaria Control Progamme to write Malaria Elimination in Zanzibar, A Feasibility Assessment. His current research is funded by the Bill & Melinda Gates Foundation, the National Institutes of Allergies and Infectious Diseases, and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health.


22 Jun 2016

How can we model the transmission of Streptococcus pneumoniae for public health and policy, capturing the...

27 May 2015

What is the estimated impact, cost, effectiveness and cost-effectiveness of a an artemisinin combination therapy (ACT) subsidy for malaria treatment targeted at children? How could leakage of the...

25 Sep 2014

Which method better prevents the spread of antibiotic resistance: aggressive treatment (high drug dosages and long treatment options for antimicrobials) or moderate treatment (low dosages and...

27 Feb 2013

How has the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) changed in recent years?

10 Jan 2012

How can antibiotics be administered to maximize their positive impact on patients and minimize the emergence of drug-resistance?

14 Sep 2011

With the prevalence of Plasmodium falciparum malaria in Zanzibar at historic lows, what are the causes of the remaining cases and how can control be improved?

15 Jun 2011

Malaria interventions have achieved success inZanzibarshould donors reallocate their resources to other malaria-endemiccountries?

28 Oct 2010

What strategies best support malaria elimination,taking into account both transmission within an endemic country and importedcases of the disease?